LoadingLoading
  • Browse By Category

  • Products
  • Services
  • Support
  • Corporate
  • Back
  • Products

  • Antibodies
  • Instruments
  • Research Kits
  • Proteins & Enzymes
  • Peptides
  • COVID-19 Assays
  • Back
  • Antibodies

  • Primary Antibodies
  • Secondary Antibodies
  • Tag Antibodies
  • Antibody Panel Packs
  • Back
  • Primary Antibodies

  • DNA Methylation Antibodies
  • Cell Structure & Function Antibodies
  • RNA Processing & Modification Antibodies
  • Chromatin & Transcription Antibodies
  • Other Primary Antibodies
  • Histone Modification Antibodies
  • Signal Transduction Antibodies
  • Metabolism Antibodies
  • Immunology & Inflammation Antibodies
  • Back
  • Cell Structure & Function Antibodies

  • DNA Damage & Repair Antibodies
  • Apoptosis & Cell Death Antibodies
  • Cell Cycle Antibodies
  • Cellular Structure Antibodies
  • Trafficking Antibodies
  • Back
  • Chromatin & Transcription Antibodies

  • DNA Replication & Transcription Antibodies
  • Chromatin Remodeling Antibodies
  • Cell Growth Antibodies
  • Development & Differentiation Antibodies
  • Back
  • Histone Modification Antibodies

  • Histone Methylation (Lysine) Antibodies
  • Histone Acetylation Antibodies
  • Histone Phosphorylation Antibodies
  • Ubiquitination & SUMOylation Antibodies
  • Histone Methylation (Arginine) Antibodies
  • Other Histone Methylation Antibodies
  • Other Histone Acetylation Antibodies
  • Histone Deacetylation Antibodies
  • Other Histone Antibodies
  • Back
  • Signal Transduction Antibodies

  • Cell Surface Receptor & Kinase Antibodies
  • Intracellular Kinase & Adaptor Protein Antibodies
  • Phosphatase Antibodies
  • Secreted Growth Factor Antibodies
  • Back
  • Metabolism Antibodies

  • Glucose Metabolism Antibodies
  • Lipid Metabolism Antibodies
  • Protein Metabolism Antibodies
  • Nucleotide Metabolism Antibodies
  • Back
  • Immunology & Inflammation Antibodies

  • Cell Marker & Receptor Antibodies
  • Cytokine Antibodies
  • Other Immunology Antibodies
  • Back
  • Antibody Panel Packs

  • Histone Modification
  • DNA Methylation
  • Back
  • Instruments

  • Sonication Devices
  • Magnets & Sample Mixers
  • Back
  • Research Kits

  • DNA Methylation
  • Chromatin & Transcription
  • Histone Methylation
  • Acetylation & Deacetylation
  • Gene Editing & Silencing
  • Sample Preparation
  • DNA Damage & Repair
  • Next Generation Sequencing
  • RNA Methylation
  • Other Histone Modifications
  • Back
  • DNA Methylation

  • DNA Bisulfite Conversion
  • DNA Methylation Quantification
  • DNA Methyltransferase & Demethylase Assays
  • Methylated DNA Immunoprecipitation
  • Methylated DNA Amplification
  • Back
  • Chromatin & Transcription

  • General Chromatin Immunoprecipitation
  • In Vitro Protein-DNA Interaction
  • Methyl-Histone Chromatin IP
  • Acetyl-Histone Chromatin IP
  • Methyl-DNA Binding Protein ChIP
  • Chromatin Analysis
  • Back
  • Histone Methylation

  • Histone Methyltransferase Assay
  • Histone Methylation Quantification
  • Histone Demethylase Assay
  • Back
  • Acetylation & Deacetylation

  • Histone Acetyltransferase (HAT) Assay
  • Histone Deacetylase (HDAC) Assay
  • Histone Acetylation Quantification
  • Back
  • Sample Preparation

  • DNA Preparation
  • Protein Preparation
  • Chromatin Preparation
  • RNA Preparation
  • Back
  • Other Histone Modifications

  • Sumoylation
  • Histone Phosphorylation Assay
  • Histone Citrullination
  • Back
  • Proteins & Enzymes

  • DNA Methylation/Demethylation Proteins
  • Methylated DNA Binding Proteins
  • Unmodified Histone Proteins
  • Chromatin Binding/Transcription Proteins
  • ADP Ribose Proteins
  • DNA Damage & Repair Proteins
  • Modified Histone Proteins
  • Back
  • DNA Methylation/Demethylation Proteins

  • DNA Demethylation Proteins
  • DNA Methylation Proteins
  • Back
  • Modified Histone Proteins

  • Histone Methylation Proteins
  • Histone Demethylation Proteins
  • Histone Acetylation Proteins
  • Histone Deacetylation Proteins
  • Histone Phosphorylation Proteins
  • Histone Sumoylation Proteins
  • Back
  • Peptides

  • Histone Methylation Peptides
  • Histone Acetylation Peptides
  • Histone Phosphorylation Peptides
  • Back
  • COVID-19 Assays

  • COVID-19 Kits
  • COVID-19 Antibodies
  • COVID-19 Proteins
  • Back
  • Services

  • DNA-based NGS Services
  • Chromatin-based NGS Services
  • qPCR-based Services
  • ELISA-based Services
  • Back
  • DNA-based NGS Services

  • Reduced Representation Bisulfite Sequencing (RRBS)
  • Whole Genome Bisulfite Sequencing (WGBS)
  • Targeted Bisulfite Sequencing
  • Back
  • Chromatin-based NGS Services

  • ChIP Sequencing (Histone Modifications)
  • Back
  • qPCR-based Services

  • Methylation-Specific qPCR (MSP)
  • Back
  • ELISA-based Services

  • Global DNA 5-mC Quantification
  • Global DNA 5-hmC Quantification
  • Global RNA 5-mC Quantification
  • Global RNA m6A Quantification
  • Histone Modification Quantification
  • Back
  • Support

  • Technical Support
  • Quality Assurance
  • Resources
  • Back
  • Technical Support

  • Submit Support Ticket
  • Back
  • Quality Assurance

  • Epigentek Gurantee
  • Risk-Free Testing: Pioneer Program
  • Product Review Program
  • Back
  • Resources

  • Epigenetics Newsletter
  • Intro to Epigenetics
  • What is Epigenetics?
  • Back
  • Corporate

  • Company Information
  • Procurement
  • Communication
  • Back
  • Company Information

  • About Epigentek
  • Press Release
  • Career Opportunities
  • Back
  • Procurement

  • Ordering Information
  • New Lab Startup Program
  • Distributors & Resellers
  • Back
  • Communication

  • Contact Us
  • Customer Feedback Survey
  • Events Calendar
Epigentek Home
Cart (0)
Datasheet
Track
Account
  • Products

    Research Kits

    • DNA Methylation
      • Global DNA Methylation Quantification
      • DNA Bisulfite Conversion
      • Methylated DNA Immunoprecipitation
      • DNMT & DNA Demethylase Assay
      • Methylated DNA Amplification
    • RNA Methylation
      • Global RNA Methylation Quantification
      • Transcriptome-Specific RNA Methylation
      • RNA Methylation Activity/Inhibition
    • Chromatin & Transcription
      • Chromatin Immunoprecipitation
      • CUT&RUN-Fast and more
      • Chromatin Accessibility
      • In Vitro Protein-DNA Interaction
    • Histone Modification
      • Histone Methylation Quantification
      • Histone Methytransferase (HMT) Assay
      • Histone Demethylase (KDM) Assay
      • Histone Acetylation Quantification
      • Histone Acetylase (HAT) Assay
      • Histone Deacetylase (HDAC) Assay
      • Histone Citrullination
      • Histone Phosphorylation
      • Histone SUMOylation
    • Protein-RNA Interaction
    • DNA/RNA Damage & Repair
      • Oxidative Cell Damage
      • Oxidative DNA/RNA Damage
    • Gene Editing & Silencing
    • Library Preparation
      • DNA-Related Library Preparation
      • RNA-Related Library Preparation
      • Chromatin-Related Library Preparation
    • Sample Preparation
      • DNA Extraction
      • RNA Extraction
      • Chromatin Extraction
      • Histone Extraction
      • Nuclear Extraction
      • Whole Cell Extraction

    Antibodies

    • DNA Modification & Regulators
      • DNA Methylation
      • DNA Regulators
    • Histone Modification
      • Histone Methylation (Lysine)
      • Histone Methylation (Arginine)
      • Other Histone Methylation
      • Histone Acetylation
      • Histone Deacetylation
      • Other Histone Acetylation
      • Histone Phosphorylation
      • Ubiquitination & SUMOylation
      • Other Histone Antibodies
    • RNA Modification & Processing
      • RNA Methylation
      • RNA Processing
    • Chromatin & Transcription
      • Chromatin Remodeling
      • DNA Replication & Transcription
      • Cell Growth
      • Development & Differentiation
    • Cell Structure & Function
      • Cell Cycle
      • DNA Damage & Repair
      • Apoptosis & Cell Death
      • Cellular Structure
      • Trafficking
    • Signal Transduction
      • Cell Surface Receptor & Kinase
      • Intracellular Kinase & Adaptor Protein
      • Phosphatase
      • Secreted Growth Factor
    • Metabolism
      • Glucose Metabolism
      • Lipid Metabolism
      • Protein Metabolism
      • Nucleotide Metabolism
    • Immunology & Inflammation
      • Cell Marker & Receptor
      • Cytokine
      • Other Immunology Antibodies
    • Other Primary Antibodies

    • Secondary Antibodies
    • Tag Antibodies
    • Antibody Panel Packs
      • Histone Modification Panel
      • DNA Methylation Panel

    Proteins & Enzymes

    • DNA Methylation
      • DNA Methylation
      • DNA Demethylation
    • Modified Histones
      • Histone Methylation
      • Histone Demethylation
      • Histone Acetylation
      • Histone Deacetylation
      • Histone Phosphorylation
      • Histone SUMOylation
    • Unmodified Histones
    • Methylated DNA Binding
    • ADP Ribose
    • Chromatin Binding/Transcription
    • DNA Damage & Repair

    Peptides

    • Histone Methylation
    • Histone Acetylation/Deacetylation
    • Histone Phosphorylation

    Instruments

    • Sonication Devices
    • Magnets & Sample Mixers

    COVID-19 Assays

    • COVID-19 Kits
    • COVID-19 Antibodies
    • COVID-19 Proteins
  • Services

    DNA-based NGS Services

    • Reduced Representation Bisulfite Sequencing (RRBS)
    • Whole Genome Bisulfite Sequencing (WGBS)

    Chromatin-based NGS Services

    • ChIP-Seq

    ELISA-based Services

    • Global DNA 5-mC Quantification
    • Global DNA 5-hmC Quantification
    • Global RNA m6A Quantification
    • Global RNA 5-mC Quantification
    • Histone Modification Quantification
    RRBS Services
  • Support

    Technical Support

    • Submit Support Ticket
    • Download Datasheet

    Resource Bulletins

    • DNA Methylation
    • RNA Methylation
    • Chromatin Remodeling
    • Histone Modifications
    • Gene Editing
    • Miscellaneous
    • Weekly Research Showcase
  • Ordering

    Procurement

    • Ordering Info & Return Policy
    • Distributors & Resellers
    • Request a Quote
    • Application Guarantee

    Promotions

    • Current Promotional Offers
    • New Lab Startup Program
    • Risk-Free Testing: Pioneer Program
    • Rewards Program
    • Product Review Program

    Company Information

    • About Us
    • Corporate Sustainability
    • Press Releases
    • Events Calendar
    • Career Opportunities
    • Contact Us
 
EpiGentek Guarantee
   Home  »  Epigenetic Resources  »  Understanding Open Chromatin Bias in CUT&RUN and CUT&Tag 
  Quick Order      Quote Lookup

Understanding Open Chromatin Bias in CUT&RUN and CUT&Tag

This article reviews published evidence that CUT&RUN and CUT&Tag can retain open chromatin-associated background despite improved controls and commercial optimizations, and explains how CUT&LUNCH offers an assay-level alternative designed to reduce non-specific DNA recovery and improve target-specific enrichment.


Enzymatic targeted cleavage methods such as CUT&RUN and CUT&Tag have transformed epigenomics research. Their low cell input requirements, streamlined workflows, elimination of sonication, and compatibility with many histone modification and transcription factor targets have made them attractive alternatives to traditional ChIP-seq. For many applications, these methods provide faster sample processing and strong sensitivity from limited biological material.

At the same time, a growing body of benchmark studies, negative-control analyses, and computational correction efforts has highlighted an important technical consideration: CUT&RUN and CUT&Tag datasets can contain accessibility-associated background signal. This does not mean these methods are unsuitable. Rather, it means researchers should understand where open chromatin-associated signal can complicate interpretation, especially when studying targets with weak enrichment, broad distribution, or biologically meaningful occupancy outside highly accessible regulatory regions.

The source of accessibility-associated background differs between CUT&RUN and CUT&Tag. In CUT&RUN, the original method was designed to minimize background by performing brief, low-temperature MNase cleavage before the tethered nuclease could diffuse and cleave accessible chromatin. Later negative-control studies, however, show that recurrent high-signal regions can still appear in CUT&RUN datasets and may persist after standard peak calling and ENCODE blacklist filtering. In CUT&Tag, the concern is more direct because Tn5 has inherent affinity for exposed DNA, and elevated salt conditions are commonly used to reduce non-specific pA-Tn5 or pAG-Tn5 binding to accessible chromatin regions. (CUT&RUN, eLife 2017; CUT&Tag, Nature Communications 2019; CUTAC, eLife 2020)

A 2025 benchmark study comparing CUT&RUN, CUT&Tag, and ChIP-seq in haploid round spermatids reported that "signals in CUT&Tag and CUT&RUN were more enriched in accessible chromatin compared to those in ChIP-seq" and concluded that these findings suggest CUT&Tag and CUT&RUN may exhibit bias toward more accessible chromatin. Because this benchmark was performed in a specific biological system, it should not be interpreted as proving the same magnitude of bias across all cell types and targets. However, it provides recent comparative evidence that accessibility-associated enrichment can remain detectable even in optimized workflows. (Wang et al., Frontiers in Cell and Developmental Biology, 2025. Link)

This accessibility-associated signal becomes especially important in negative controls. IgG-only or no-antibody controls can generate recurrent peak patterns that overlap with regions of high genomic accessibility or other problematic genomic regions. This matters because an apparent peak in a CUT&RUN or CUT&Tag dataset may reflect true target binding, accessibility-associated background, recurrent technical artifact, or a combination of these effects.

CUT&Tag and CUT&RUN accessibility bias compared with ChIP-seq
CUT&Tag and CUT&RUN reads show stronger enrichment in ATAC-seq peaks than ChIP-seq in a 2025 benchmark study. The figure quantifies the fraction of H3K4me3, H3K27me3, and CTCF reads located in ATAC-seq-defined accessible chromatin regions within common peaks. The authors concluded that CUT&Tag and CUT&RUN signals were more enriched in accessible chromatin than ChIP-seq, suggesting a bias toward more accessible chromatin. (Wang et al., Frontiers in Cell and Developmental Biology, 2025. Full paper - see Figure 3F and Supplementary Figure S5E)

How the field has responded to open chromatin bias

Importantly, open chromatin bias and recurrent background regions are not hidden issues. Method developers, academic users, and commercial suppliers have recognized that CUT&RUN and CUT&Tag require careful controls and data interpretation. Over time, the field has introduced several practical countermeasures, including IgG or no-antibody negative controls, optimized salt conditions, spike-in normalization, improved peak-calling workflows, ENCODE blacklist filtering, and CUT&RUN-specific suspect-region lists.

The field's response has evolved alongside the methods themselves. CUT&RUN was introduced in 2017 as a targeted nuclease strategy for mapping protein-DNA interactions. CUT&Tag was introduced in 2019 as a Tn5-based targeted tagmentation method for efficient chromatin profiling from small samples and single cells. In 2020, CUTAC demonstrated that related tethered tagmentation chemistry could be adapted specifically for chromatin accessibility mapping, further highlighting the close relationship between these enzymatic workflows and accessible chromatin. (CUT&RUN, eLife 2017; CUT&Tag, Nature Communications 2019; CUTAC, eLife 2020)

By 2023, the problem had become concrete enough that researchers published a dedicated CUT&RUN suspect list of problematic genomic regions. Nordin et al. compiled human and mouse suspect lists from CUT&RUN data, identifying regions consistently called as peaks in negative controls. The authors reported that these regions may persist even after SEACR or MACS2 peak calling against negative controls and after ENCODE blacklist removal. They also experimentally validated the suspect lists using repeated negative-control experiments and reported that the lists captured more than 80% of the peaks identified in those controls. This was a transparent and useful contribution to the field, and it gave researchers a practical tool for improving CUT&RUN data interpretation. (Nordin et al., Genome Biology, 2023. Link)

Commercial CUT&RUN and CUT&Tag suppliers have also attempted to address these issues through optimized wash conditions, high-salt buffers, recommended negative controls, spike-in normalization options, and analysis recommendations. These are meaningful improvements, and for many targets they can produce useful, high-quality datasets. However, most of these measures are mitigation strategies that reduce, reveal, normalize, or correct background rather than fully eliminating its source. They do not fully remove the underlying risk that MNase- or Tn5-based workflows can generate accessibility-associated or recurrent non-target signal under some experimental conditions.

Field response What it helps address Why it may still be insufficient
IgG or no-antibody controls Help identify non-specific peaks and background signal. Controls reveal the problem but do not prevent non-specific chromatin release during the assay.
High-salt washes and optimized buffers Reduce some non-specific binding and improve signal-to-noise. They may not fully overcome accessibility-associated enzyme behavior, and harsher conditions may affect weak or transient protein-chromatin interactions.
ENCODE blacklist and CUT&RUN suspect-list filtering Remove known problematic genomic regions from downstream analysis. Filtering improves interpretation but also confirms that recurrent false-positive regions can remain common enough to require post-assay correction.
Spike-in normalization Improves comparison between samples and helps control for technical variation. Normalization does not distinguish true target enrichment from accessibility-associated or recurrent background signal at specific genomic loci.
Computational correction tools Adjust read distributions and reduce accessibility-associated signal after sequencing. Correction cannot fully recover information that was biased during the experimental release or tagmentation step.

Additional context comes from computational correction efforts for CUT&Tag. PATTY was developed specifically to address Tn5-related open chromatin bias in CUT&Tag datasets. The authors reported that Tn5 preference toward accessible chromatin can alter CUT&Tag read distributions and confound downstream analysis, especially in sparse single-cell data. They further reported that open chromatin bias was present across published CUT&Tag datasets, including datasets generated with optimized high-salt protocols. While this work is still in preprint at time of writing, it provides potential and emerging evidence to support the practical concern that improved washing and analysis workflows may reduce, but not necessarily eliminate, assay-level bias. (PATTY bioRxiv preprint; PubMed record)

These concerns also appear in user discussions and troubleshooting forums, where researchers frequently describe high IgG background, ATAC-like peak patterns, and uncertainty around peak interpretation. While such reports are anecdotal, they reflect practical pain points that align with the published technical literature.

Together, these developments show that the field has handled the issue transparently and constructively. The key limitation is that most solutions are control-based, wash-based, filter-based, normalization-based, or computational. They help researchers identify, reduce, normalize, or filter accessibility-associated background, but they do not fully remove the risk of artifact generation at the experimental cleavage or tagmentation stage. For researchers seeing high IgG background, ATAC-like peak patterns, excessive promoter or enhancer signal, or weak discrimination between target and control tracks, a method-level alternative may be more appropriate than adding another layer of correction.

These characteristics carry practical consequences for data interpretation. Active histone marks such as H3K4me3 and H3K27ac, as well as many transcription factors, are frequently associated with promoters, enhancers, and other accessible regulatory elements. In these contexts, true biological enrichment and accessibility-associated background may overlap. For repressive marks, weakly enriched transcription factors, or targets expected to bind outside highly accessible regions, accessibility-associated background can obscure more subtle signals or complicate peak-calling decisions.

For this reason, well-designed CUT&RUN and CUT&Tag studies often benefit from multiple safeguards: matched IgG controls, sufficient biological replicates, careful digestion or tagmentation optimization, spike-in normalization when appropriate, suspect-region filtering, and orthogonal validation by qPCR, ChIP-seq, ATAC-seq, or other methods. These steps help improve confidence, but they also add time, cost, and analytical complexity.

Addressing the issue at the root with CUT&LUNCH

While CUT&RUN and CUT&Tag remain valuable methods when used with appropriate controls and analysis practices, researchers who repeatedly observe high background or accessibility-associated signal may benefit from considering an assay designed to reduce non-specific chromatin release at the experimental stage.

EpigenTek developed CUT&LUNCH (Cleavage Under Target and Liberate Unique Nucleic Complex Homogenously) for this type of challenge. Rather than relying only on post-assay filtering, high-stringency washing, or computational correction, CUT&LUNCH uses an antibody-directed dual-end cleavage approach with a unique enzyme (not MNase or Tn5) designed to selectively release and recover target-associated DNA fragments while reducing non-specific DNA recovery. EpigenTek's product development data shows that CUT&LUNCH provides low non-specific DNA binding of approximately 3-5%, completes the stand-alone assay in less than two hours, does not require ConA immobilization, and supports analysis with existing ChIP-seq bioinformatics pipelines. (CUT&LUNCH overview; CUT&LUNCH Assay Kit)

For sequencing applications, the EpiNext CUT&LUNCH-Seq Kit is designed to move from intact cells to ready-to-use library DNA in under three hours. The workflow avoids nuclei isolation, does not require a secondary antibody, and is designed to generate target-enriched DNA libraries while reducing non-specific protein-DNA recovery. (CUT&LUNCH-Seq Kit)

Common CUT&RUN/CUT&Tag challenges Typical mitigation approach CUT&LUNCH approach
Non-specific or recurrent control peaks IgG/no-antibody controls, blacklist filtering, suspect-list filtering. Designed to eliminate non-specific DNA at the assay level.
Open chromatin-associated signal High-salt conditions, optimized washes, computational correction. Designed to recover only targeted open chromatin signals via affinity pulldown.
Added analysis complexity Additional controls, filtering steps, spike-ins, and orthogonal validation. Designed to produce cleaner input for downstream ChIP-seq style analysis pipelines.

EpigenTek's comparative performance data show that CUT&LUNCH histone marker peak profiles are consistent with ENCODE ChIP-seq profiles and produce fewer false signals than traditional CUT&RUN when tested in MCF-7 cells. For researchers who need high-specificity protein-DNA interaction data, these results support CUT&LUNCH as a practical assay-level option for reducing accessibility-associated background and non-specific cleavage artifacts. (Data summary)

CUT&RUN and CUT&Tag remain useful, widely adopted methods when paired with the right controls and analysis practices, but their known accessibility-associated background makes method selection important. The field has introduced multiple mitigation strategies, including optimized buffers, negative controls, suspect-region filtering, spike-in normalization, and computational correction. However, recent evidence still suggests that these approaches reduce rather than fully eliminate the issue. For laboratories that need cleaner target-specific enrichment with less accessibility-associated background, CUT&LUNCH provides a practical assay-level alternative.

For laboratories troubleshooting CUT&RUN or CUT&Tag background, or for researchers planning experiments where peak specificity is critical, CUT&LUNCH offers a streamlined alternative designed to improve target selectivity, reduce non-specific background, and simplify downstream interpretation.

Learn more about CUT&LUNCH

References and additional reading

  • Skene and Henikoff. An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites. eLife, 2017. View article
  • Kaya-Okur et al. CUT&Tag for efficient epigenomic profiling of small samples and single cells. Nature Communications, 2019. View article
  • Henikoff et al. Efficient chromatin accessibility mapping in situ by nucleosome-tethered tagmentation. eLife, 2020. View article
  • Nordin et al. The CUT&RUN suspect list of problematic regions of the genome. Genome Biology, 2023. View article
  • Wang et al. Benchmark comparison of CUT&RUN, CUT&Tag, and ChIP-seq signal enrichment in accessible chromatin. Frontiers in Cell and Developmental Biology, 2025. View article
  • Hu et al. PATTY corrects open chromatin bias for improved bulk and single-cell CUT&Tag analysis. bioRxiv preprint, first posted 2025 and revised 2026. View preprint | PubMed record
  • EpigenTek CUT&LUNCH overview. View page
  • EpiNext CUT&LUNCH Assay Kit. View product
  • EpiNext CUT&LUNCH-Seq Kit. View product

Epigenetic Resources
  • DNA Damage & Repair
  • DNA Methylation»
  • RNA Methylation»
  • Chromatin Remodeling»
  • Histone Modifications»
  • Gene Editing
  • Miscellaneous
  • Weekly Research Showcase

Suggested Reads:

m6A RNA Methylation in Cancer Immunity and Therapeutic Resistance
cfDNA Methylation in Liquid Biopsy Research: Where Global 5-mC, 5-hmC, Enrichment, and RRBS Readouts Fit
Understanding Open Chromatin Bias in CUT&RUN and CUT&Tag
Unlocking Rapid Chromatin Profiling with CUT&LUNCH Technology
Company
About Epigentek
Press Releases
Events Calendar
Corporate Sustainability
Career Opportunities
What Is Epigenetics?
Contact Us
Ordering
Ordering Info & Return Policy
Distributors & Resellers

Support
Technical Support
Download Datasheets
Resource Bulletins
Promotions & Offers
Current Promotions
New Lab Startup Program
Risk-Free Testing: Pioneer Program
Rewards Program
Product Reviews
Application Guarantee
Sign Up For Exclusive Offers
Request a Quote
Stay Informed




Terms & Conditions | Privacy Policy | Site Map
Copyright © EpigenTek Group Inc. All rights reserved.
  • Stay Informed:
Terms & Conditions | Privacy Policy Copyright © EpiGentek